Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Transverse Myelitis: later-stage trial registry

2 of 6 indexed Transverse Myelitis trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Transverse Myelitis: 6 US clinical trials tracked, 2 recruiting.

Transverse Myelitis is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is University of Alabama at Birmingham, running 2 of these trials.

Enrollment posture brief

Registry condition transverse-myelitis

OPEN 2 | RECR 33% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Transverse Myelitis (this)33%
Open-enrollment share among volume-matched conditions near Transverse Myelitis

Transverse Myelitis lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Transverse Myelitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Transverse Myelitis is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Transverse Myelitis research.

    University of Alabama at Birmingham accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Transverse Myelitis enrolment sits around 155 participants.

    Median target enrolment is 155 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.

  4. Transverse Myelitis splits between interventional and observational designs.

    3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

University of Alabama at Birmingham 2 trials
Burke Medical Research Institute 1 trials
Accelerated Cure Project for Multiple Sclerosis 1 trials
Beth Israel Deaconess Medical Center 1 trials
University of Texas Southwestern Medical Center 1 trials

Named interventions

Most-linked intervention names on Transverse Myelitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

interferon beta 1a 30 ug IM once weekly Drug
1 trials
Seated exercise Behavioral
1 trials
expressive writing Behavioral
1 trials

US sites by state

Facility locations filed on Transverse Myelitis trials. A trial with sites in several states counts in each.

Texas 3 trials
New York 3 trials
Ohio 2 trials
Massachusetts 2 trials
Georgia 2 trials
Alabama 2 trials
Wisconsin 1 trials
Virginia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Transverse Myelitis page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Transverse Myelitis condition card totals 6 registered trials; most-linked intervention interferon beta 1a 30 ug IM once weekly; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.